Objective: Integrins exert regulatory functions in placentogenesis. Null mutation of certain integrin a subunits leads to placental defects with subsequent fetal growth restriction or embryonic lethality in mice. So far, the placental role of a8 integrin remains to be determined. Methods: Localization of a8 integrin and its ligands, fibronectin (FN) and osteopontin (OPN), was studied by immunohistochemistry in human, rat, and mouse placenta. The vascularization of the placental labyrinth layer of a8 integrindeficient mice was determined by CD31 staining. In humans, a8 integrin expression was assessed via real-time polymerase chain reaction in healthy placentas, in the placental pathologies such as intrauterine growth restriction (IUGR), preeclampsia, and HELLP-syndrome (hemolysis, elevated liver enzymes, low platelet count), as well as in primary extravillous trophoblasts (EVT) and villous trophoblasts. Results: In humans, a8 integrin was detected in first and third trimester syncytiotrophoblast and EVT. Although OPN showed the same localization, FN was observed in EVT only. No expressional changes in a8 integrin were detected in the placental pathologies studied. Rodent placenta showed a8 integrin expression in giant cells and in the labyrinth layer. The localization of OPN and FN, however, showed species-specific differences. Knockout of a8 integrin in mice did not cause IUGR, despite some reduction in labyrinth layer vascularization. Conclusion: a8 Integrin is expressed in functional placental compartments among its ligands, OPN and/or FN, across species. Although this may point to a regulatory role in trophoblast function, our data from a8 integrin-deficient mice indicated only mild placental pathology. Thus, the lack of placental a8 integrin seems to be largely compensated for.
Introduction
The maintenance of placental exchange and endocrine function is essential for fetal development and survival during pregnancy. Major structural deficiencies of this feto-maternal interface can result in early abortion. It can also lead to the development of placental pathologies, such as preeclampsia (PE), HELLP-syndrome (hemolysis, elevated liver enzymes, low platelet count), and intrauterine growth restriction (IUGR), 1-3 all of which are associated with an increased rate of perinatal morbidity. 4, 5 During placentogenesis, the family of integrin matrix receptors plays an important role in adapting trophoblast cellular functions to the extracellular microenvironment via mediation of cell-matrix interactions. 6, 7 Integrins are transmembrane, heterodimeric glycoproteins consisting of 1 aand 1 b-subunit. 8 Their extracellular domain functions as a matrix adhesion molecule, while their intracellular domain mediates cellular functions like survival, migration, differentiation, and proliferation after ligand binding. [9] [10] [11] [12] The placental integrin expression pattern is dependent on the developmental stage and localization of the trophoblast. In the first trimester, trophoblasts are positive for a6b4 integrin, which is present at the basal surface of cytotrophoblasts (CTBs) throughout pregnancy and at the basal syncytial surface. From the second trimester, a3b1, avb3, and a5b1 integrins are detected in CTB and in the syncytiotrophoblast (SCT), regulating mainly adhesion, cell turnover, and possibly syncytialization. 13, 14 Trophoblast differentiation into extravillous trophoblasts (EVTs) is accompanied by a shift in integrin expression: a6b4 integrin expression is lost, whereas a1b1, a4b1, a5b1, as well as avb3 and a6b1 integrins are upregulated to support EVT invasion and anchorage. 14 The decisive role for integrins, in the development of the placenta, is emphasized by studies in mice with null mutations of some integrin a subunits. These animals showed a disruption of functional placental compartments, accompanied by an increased embryonic lethality. For example, Yang et al 15 were able to show that a deficiency in the a4 integrin subunit resulted in a failure of the allantois to fuse with the chorion at E 8. 5 .
In embryos deficient of a7 integrins, Welser et al 16 found defects of placental vascular development. Placentas from E 9.5 and E 13.5 showed a disruption of the infiltration of the spongiotrophoblast (ST) layer into the labyrinth, accompanied by fetal growth restriction.
In the placenta, most integrins have been thoroughly investigated. Up to now, the role of a8 integrin has not been studied. The a8 integrin subunit is known to dimerize exclusively with the b1 integrin subunit. 17 Ligands of a8b1 integrin are fibronectin (FN) and osteopontin (OPN), among others. [18] [19] [20] Both FN and OPN are abundantly expressed in the placenta: FN expression is detected in the villous stroma and the decidua. 21 Osteopontin is a major constituent of the uteroplacental compartment and known as a marker of decidualization. 22 a8 Integrin-deficient mice frequently show abnormalities in embryonic development, leading to uni-or bilateral renal agenesis in part of the animals and to a malformation of stereocilia in the inner ear. 23, 24 Moreover, a8 integrin-deficient mice are highly susceptible to mechanical or inflammatory renal or vascular organ damage. [25] [26] [27] Thus, a8 integrin seems to play a pivotal role in maintaining structural and functional tissue integrity in these organs.
The cellular effects of a8b1 integrin binding are strongly cell type dependent. It inhibits migration and stimulates proliferation in smooth muscle cells and in human intestinal crypt cells. In the latter, overexpression of a8b1 integrin also induces cell differentiation. [28] [29] [30] [31] In contrast, knockdown of a8b1 integrin increases proliferation in mesangial cells. 32 Similarly, opposing observations were made upon investigating cell survival. Acute knockdown of a8b1 integrin lead to resistance against anoikis in intestinal cells, but its expression guarded neuroendocrine cells from apoptosis. 33, 34 In light of the findings that a8 integrin regulates cell survival, proliferation, differentiation, and migration in many cell types and that the placenta is an organ in which apoptosis, proliferation, differentiation, and migration of trophoblast cells occur tightly regulated throughout pregnancy, we hypothesized that a8 integrin is expressed in placental compartments, which could argue for a role of a8 integrin for placental development and homeostasis. Therefore, we analyzed the expression and localization of a8 integrin and its ligands, FN and OPN, in human and rodent placenta. Moreover, we studied a8 integrin expression in placental pathologies (PE, HELLP, IUGR) and investigated the placentas of a8 integrin-deficient mice.
Materials and Methods

Animal Procedures
All animal procedures were carried out in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and were approved by the local government authorities (Regierung von Mittelfranken, approval numbers AZ # 54-2531.31-12/06 and AZ # 54-2532.1-17/08) after evaluation of the local government's review board for animal research ethics. All surgeries were performed under isoflurane anesthesia and all efforts were made to minimize suffering. The animals were housed in a room maintained at 22 C + 2 C, exposed to a 12-hour dark/ light cycle, and were allowed unlimited access to standard chow and tap water. The mouse model of a8 integrin-deficient (Itga8 À/À ) mice was previously described. 25 We used Itga8 À/À mice and their wild-type (WT) litters from a heterozygous breeding for mating. This mouse strain is kept on a mixed genetic background 129Sv/ C57BL6. For collection of Itga8 À/À placentas, female Itga8 À/À and male Itga8 þ/À were mated; for collection of WT placentas, female WTs and male Itga8 þ/À were mated. The placentas were collected at day 19.5 of gestation and were genotyped. Seven WT placentas and 5 Itga8 À/À placentas from different litters were used for expression analysis. The neonatal weights were assessed from 22 WT (from 5 different litters) and 16 Itga8 À/À (from 5 different litters). Mouse placentas were obtained from these mice at day 17.5 of pregnancy. Pregnant female Wistar rats were obtained from Charles River (Sulzfeld, Germany). Rat placentas were obtained following maternal sacrifice via bleeding in deep anesthesia at day 19 of pregnancy. All rodent placentas were fixed in methyl Carnoy or ice-cold 4% paraformaldehyde for embedding in paraffin or were snap frozen for messenger RNA (mRNA) preparation.
Human Placental Tissue
This study was conducted in accordance with principles outlined in the Declaration of Helsinki 35 and was approved by the institutional ethics committee of the medical faculty of the University of Erlangen-Nürnberg (#2625-02/28/02 and #2180-05/05/ 04). Written informed consent was given by every patient.
Placental sampling and tissue handling were described earlier in detail. 36, 37 For immunohistochemical analysis, fresh samples of human placenta were excised immediately after placental delivery, fixed in 4% formaldehyde, and embedded in paraffin. We analyzed tissue sections of healthy human appropriate for gestational age (AGA) placentas (n ¼ 5) and of pregnancies complicated by IUGR, PE, and HELLP ranging from 36 gestational weeks to term (n ¼ 5 each). Cases of IUGR were not complicated by PE and vice versa. The diagnosis of IUGR, PE, and HELLP was based on generally accepted criteria outlined previously. 37, 38 Moreover, placental sections of first-trimester abortions (n ¼ 4) were examined (kind gift of the Department of Pathology at the University of Erlangen).
For quantitative polymerase chain reaction (PCR) gene expression analysis, a separate set of placental samples containing third trimester AGA (n ¼ 25), IUGR (n ¼ 18), PE (n ¼ 18), and HELLP (n ¼ 8) samples was used. These samples were obtained in a standardized sterile procedure immediately after placental delivery. A 2 Â 2 cm segment, total depth ranging from basal plate to chorionic membrane, was excised at the central region of the placenta using a scalpel blade. Macroscopic calcifications were avoided. Amniotic membranes and basal plate were removed. Samples were immediately snap frozen in liquid nitrogen and stored at À80 C until further processing.
In a third set of experiments, primary trophoblast cells were isolated from uncomplicated term pregnancies after elective cesarean section as previously described in detail. 36, 39 We isolated decidual stroma cells (DSCs), EVTs, and villous cytotrophoblasts (VT) from 3 total AGA placentas. The procedures were carried out under sterile conditions. Protocols for immunomagnetic bead separation of VT and EVT isolation have been described in detail elsewhere. 36, 40 In short, for the fractionation of EVT, placental basal plate was grossly removed, minced, and subjected to enzymatic digestion involving trypsin, DNase I (Sigma-Aldrich, Taufkirchen, Germany), and dispase (BD Biosciences, Heidelberg, Germany). After filtration and centrifugation, the resuspended cells were layered over lymphocyte separation medium 1077(Sigma-Aldrich). After erythrocyte lysis, cells were resuspended in MACS buffer (Miltenyi Biotec, Bergisch Gladbach, Germany) containing DNase I and subjected to Fc-blocking (Miltenyi Biotec), followed by incubation with anti-human leukocyte antigen (HLA)-G-phycoerythrin (PE) antibody (clone 87G; Biolegend, Fell, Germany). Subsequently, cells were incubated with anti-PE magnetic beads (Miltenyi Biotec), washed and loaded on magnetized LS columns (Miltenyi Biotec), and the flow-through discarded. Isolated EVTs were HLA-G positive and CD45/CD3/CD56 negative, as shown by multiple FACS (FACSCalibur; BD Biosciences) analyses. 40 Fractionation and cultivation of human VT was performed based on the trypsin-DNase-dispase/Percoll method 41, 42 in conjunction with negative immunomagnetic bead separation (Miltenyi Biotec) via the PE-labeled surface marker antibodies HLA-ABC (clone W6/32; Biolegend, London, United Kingdom) and CD45 (clone BRA-55; Sigma-Aldrich), as previously described in detail. 40 Percoll came from Sigma-Aldrich. Isolated VTs were 99% HLA-ABC and CD45 negative. 40 Isolation of DSCs from placenta via selective adhesion was carried out by modifying the protocols of Frank et al 43 and Lockwood et al 44 , as previously published in detail. 39 In short, enzymatic digestion of minced placental basal plate was carried out with collagenase type I (Gibco-BRL, Eggstein, Germany) and DNase I (Sigma-Aldrich). Following erythrocyte lysis, the filtrated and washed cells were seeded. Decidual stromal cells were separated from contaminating cells via their reduced adherence and purified by multiple passaging. Purity was assessed after the third passage via FACS analysis (FACSCalibur) using the following antibodies: vimentin (clone V9; Dako, Hamburg, Germany), CD45 (Caltag Laboratories, Hamburg, Germany), CD9 (Pharmingen, San Diego, California), CD31, and CD14 (Immunotec, Quebec, Canada).
Gene Expression Analysis
Gene expression analysis was performed as previously described. 37 In short, for RNA purification, peqGold TriFast reagent (Peqlab, Erlangen, Germany) was used. Following RNA pretreatment with DNase I (Sigma-Aldrich), complementary DNA (cDNA) synthesis was conducted using the high-capacity cDNA reverse transcription kit (Life Technologies, Darmstadt, Germany) in a thermal cycler (ABI2720). Quantification of a8 integrin mRNA expression was achieved by quantitative real-time PCR analysis using the SYBR Select Master Mix (Life Technologies) with 18srRNA as housekeeping gene. Measurements were performed in duplicates. Primers were designed using Primer 3 software. 45 The following primers were used for human tissue (Eurofins Genomics, Ebersberg, Germany): ITGA8 forward 5 0 -GCGCAGTCCT GAAAGTCAGG-3 0 , reverse 5 0 -TCTGGAGGAAGGTGT GGGC-3 0 and 18srRNA forward 5 0 -GCAATTATTCCCCAT GAACG-3 0 , reverse 5 0 -GGCCTCACTAAACCATCCAA-3 0 . For mouse tissue, primers are listed in Table 1 .
Immunohistochemistry
Unless stated otherwise, all materials came from Sigma-Aldrich. Tissue fixation in methyl Carnoy and paraformaldehyde and embedding in paraffin were performed as previously described. 46, 47 After cutting 4-mm paraffin sections with Leica CM3050S microtome (Leica Instruments, Wetzlar, Germany), sections were deparaffinized in xylol and rehydrated by bathing in decreasing concentrations of alcohol. The endogenous peroxidase activity was blocked for 20 minutes at room temperature with 3% H 2 O 2 in methanol.
For Itga8 staining, human and rat placental sections were incubated with 1% bovine serum albumin (BSA) in Tris-buffered saline (TBS; 1% BSA/TBS) at 37 C for 30 minutes, whereas sections of mice placenta were incubated using fetal calf serum (FCS) under the same conditions.
For the FN staining of all sections and for the OPN staining of only rat and human sections, they were coated with 1% BSA/ Forward Reverse For staining of trophoblasts in human first trimester serial sections, we used a mouse monoclonal pan-cytokeratin antibody (clone 80, 1:500; Kamiya Biomedical Co, Seattle) at a dilution of 1:200 in conjunction with the labeled streptavidin binding (LSAB) þ horseradish peroxidase (HRP) kit (Dako) and hematoxylin as per the manufacturer's instructions, as previously published. 49 Sections were analyzed using a Leitz Aristoplan microscope (Leica Microsystems, Wetzlar, Germany). The description of rodent placental anatomy was based on nomenclature published by others before. [50] [51] [52] 
Determination of Labyrinth Vascularity
To stain vascular structures within the labyrinth, CD31 (Pecam-1) immunofluorescent (IF) staining was performed. Paraffin sections were deparaffinized and rehydrated, and endogenous peroxidase activity was blocked as described above. Unmasking was performed with cooking in target retrieval solution (TRS; Dako) for 20 minutes and cooling in TRS for another 10 minutes. After incubating with FCS at 37 C for 30 minutes, the sections were coated with rabbit polyclonal anti-CD31 antibody (dilution 1:50, ab 28364; Abcam) and incubated overnight at 4 C. After washing, slides were incubated with the secondary fluorescent antibodies (Alexa Fluor 555 red at a dilution of 1:500 for 2 hours and 4 0 ,6-diamidino-2-phenylindole (DAPI, blue) at a dilution of 1:2000 for 2 minutes, all from Life Technologies, Darmstadt, Germany) and embedded in Mowiol. Immunofluorescent sections were analyzed using a Nikon Eclipse 80i microscope (Nikon GmbH, Düsseldorf, Germany).
To screen for potential defects of vascular development in the labyrinth layer 16 of Itga8 À/À mice, the percentage of vascular elements (CD31 positive) within the murine labyrinth was analyzed over 6 random fields of 2 IF slides per animal (5 Itga8 À/À vs 5 WT) at Â400 magnification using ImageJ software (1.48v; NIH 53 ). For standardization of our stereologic analysis, we chose those representative placental cross sections (30 mm apart) with the largest vertical diameter in each animal.
Statistical Analysis
Results were expressed as mean + standard error of the mean (SEM) unless stated otherwise. Statistical analyses were performed using GraphPad Prism Version 4.0c (GraphPad Software, San Diego, California). Groups were compared using 2-sided unpaired t test. A P value of <.05 was considered statistically significant.
Results
Localization of a8 Integrin in Human First Trimester Placenta
ITGA8 staining was evident in extravillous and villous placental compartments (Figure 1a ). Extravillous cells (ie, DSCs and EVT) both showed ITGA8 antibody staining (Figure 1b ). Extravillous trophoblasts stained both ITGA8 and pan-cytokeratin positive in serial sections of first trimester placenta (Figure S4 a, c). In the first trimester villi, a8 integrin was majorly localized in the SCT showing a basoapical staining pattern, with minor ITGA8 staining in the adjacent villous trophoblast (VT, Figure 1c ). Similar to EVT, SCT of the first trimester stained ITGA8 and pan-cytokeratin positive ( Figure S4 ). We found strong FN immunoreactivity in the basal plate matrix surrounding EVT (Figure 1e ). Villous stroma (Figure 1d 
Localization of a8 Integrin in Healthy Human Third Trimester Placenta and Placental Pathologies
Similar to our findings in human first trimester placenta, immunostaining of a8 integrin was evident in all placental compartments of the third trimester placenta (Figure 2a-c) . Basal plate EVT showed a strong ITGA8 immunoreactivity with a predominant membranous staining pattern (Figure 2b) , even more pronounced than in the first trimester EVT (Figure 1b ). In the third trimester placental villi, the SCT stained positive for ITGA8, whereas VT stained only weakly for ITGA8 ( Figure 1c ). Similar to the findings in first trimester placenta (Figure 1d ), basal plate EVT themselves were negative, but there was a strong extracellular immunoreactivity to FN in the basal plate (Figure 2d and e ). As seen in the first trimester placenta (Figure 1f ), SCT and VT stained FN negative (Figure 2f ). Osteopontin staining pattern at term reflected findings from the first trimester (Figure 1g -i), with positive EVT (Figure 2g -h), SCT (Figure 2g and i) and VT (Figure 2i ). As described by others, 54 we also found positive OPN membrane staining of fetal erythrocytes, while maternal blood cells showed no OPN immunoreactivity (data not shown).
Expression of a8 Integrin in Primary Human Trophoblasts and Placental Pathologies
Analysis of ITGA8 mRNA expression in primary human third trimester EVT and VT by real-time PCR showed a significantly higher ITGA8 expression in EVT compared to VT (Figure 2j ), which is in accordance with our findings from the histological analyses. The comparison of healthy and pathological placental tissue showed no significant difference in ITGA8 expression (Figure 2k ). This finding was in line with our immunohistochemical analyses of placental ITGA8 expression in these entities, where we did not detect clear-cut differences in ITGA8 staining of pathological and control placentas (data not shown).
Localization of a8 Integrin in Rat Term Placenta
Maternal decidua and trophoblast giant cells (Figure 3b ) stained Itga8 positive, whereas the ST (Figure 3a ) and the labyrinth zone (LZ, Figure 3c ) showed no Itga8 immunoreactivity.
All placental compartments of the rat placenta stained FN positive (Figure 3d and e), except for the LZ (Figure 3f ). Fibronectin staining appeared in the extracellular matrix surrounding GC and cells of the ST layer (Figure 3e ), similar to staining patterns in the basal plate surrounding human EVT (Figure 2d and e ). Osteopontin expression was predominantly found in GC and the adjacent ST (except for OPN-negative glycogen cells; Figure 3h) , with a cytoplasmatic staining pattern (Figure 3h) . In contrast to the negative FN stain (Figure 3f ), the rat LZ showed strong OPN immunoreactivity (Figure 3i) , with a pronounced OPN staining in mononuclear sinusoidal trophoblast giant cells (sTGCs; Figure 3i , magnification).
Localization of a8 Integrin in Mouse Term Placenta
Similar to the findings in rat placenta, we observed Itga8 immunoreactivity in the decidua and in GC (Figure 4a and b) . However, Itga8 staining pattern in the mouse was slightly different from the rat (Figure 3c) . In contrast to the rat, the maternal decidua of mice was Itga8 negative (Figure 4a ), the ST showed a very weak Itga8 immunoreactivity (Figure 4b) , and the LZ (Figure 4c ) stained Itga8 positive. Examining the LZ at a higher magnification (Figure 4c ), we found strong Itga8 immunoreactivity in its syncytial layers (Syn), with negative Itga8 staining of fetal vessel endothelium and mononuclear sTGCs (Figure 3c ). As seen in the rat (Figure 3d-f) , extracellular FN deposition in the connective tissue surrounding trophoblast GC (Figure 4d and e) and ST (Figure 4e ) was found. In the mouse, positive FN immunoreactivity of the ST was more sporadic when compared to the rat. Glycogen-containing cells were FN negative (Figure 4e) . In contrast to the rat, we detected a strong FN staining in the mouse LZ (Figure 4f , magnification) with a specific FN immunoreactivity in its Syn. Similar to our findings in the rat placenta (Figure 3g-i) , the murine placenta (Figure 4g -i) expressed OPN in GCs and the adjacent ST. Osteopontin immunoreactivity of the latter seemed more pronounced in mice (Figure 4h ). Glycogen cells remained OPN negative (Figure 4h ), whereas the LZ showed some OPN immunoreactivity (Figure 4i ). As seen in the rat (Figure 3i ), sTGCs showed a pronounced positive OPN staining (Figure 4i ).
Determination of Labyrinth Vascularity in a8 Integrin-Deficient Mice
Comparison of murine Itga8 knockout (Itga8 À/À ) and WT placentas did not reveal any alterations in size or the relation of the functional compartments to each other (data not shown). However, when examining the labyrinth layer in more detail, some reduction in vascularity was evident, which was assessed by quantifying labyrinthine CD31 immunoreactivity (Figure 5a ). On the other hand, CD31 mRNA expression was not different in Itga8 À/À and WT placentas ( Table 2) . To test if placentas lacking Itga8 are insufficient, we compared birth weights of Itga8 À/À and WT mice. No differences in birth weights were detected (Figure 5b ). We hypothesized that in the placenta, the lack of Itga8 might be compensated for by other integrin chains. Expression analysis of candidate integrin chains Itga5, ItgaV, Itga2, and Itga6 revealed no differences in expression levels in Itga8 À/À and WT placentas ( Table 2 ).
Discussion
We determined the expression of a8 integrin and its tripeptide Arg-Gly-Asp (RGD) sequence containing ligands FN and OPN 18, 20 in human and rodent placenta. Prominent immunostaining for a8 integrin was detected in human EVT and SCT with weaker staining of villous CTB. Staining for a8 integrin in human placenta and for FN and/or OPN revealed common patterns in the examined placental compartments, suggesting possible interactions of a8 integrin with these ligands.
Tightly regulated expression of integrins is a prerequisite for proper placental development and governs the turnover of trophoblast cells and the invasion of EVT into the decidua, where integrins regulate spiral artery tone or establish anchorage of placental villi. 55, 56 It is known that this invasion process is accompanied by the loss of a6b4 integrin and induction of a5b1 and a1b1 integrins. 55, 56 A dysregulation of this integrin shift is associated with pathologic pregnancy outcome, such as PE, characterized by a shallow CTB invasion of the placental bed and of uterine vessels. [57] [58] [59] It is therefore conceivable that a8 integrin might also play a role in the regulation of trophoblast turnover and/or EVT invasion and anchorage in the decidua. Studies in several cell types proved a contribution of a8 integrin to the regulation of apoptosis, 26, 34 proliferation, 29, 30, 32 adhesion, 32 and migration. 32, 60 In the human placenta, a8 integrin expression was mainly located in EVT and SCT, whereas FN was localized in close vicinity of EVT in the basal plate. This is in accordance with previous studies where FN was specifically secreted by migrating basal plate EVT. 61, 62 This argues for a possible interaction of FN and a8 integrin in human EVT. In line with this finding, the amount of released FN is strongly influenced by integrin expression of trophoblast cells. 63 Osteopontin was detected in DSCs, EVT, SCT, and VT arguing for possible interactions with a8 integrin in these cells.
Our immunohistological analysis of human first and third trimester placenta shows a comparable localization of a8 integrin, FN, and OPN in placental compartments at both time points. The localization of a8 integrin in the placental compartments argues for a possible role in trophoblast turnover and/or differentiation and in EVT invasion or anchorage.
We did not observe an association of a8 integrin expression levels and staining patterns with human placental pathologies, such as IUGR, PE, and HELLP, as was partly shown for its ligand OPN. 64 Moreover, we did not observe a reduction in birth weight in our a8 integrin-deficient mice. This observation seems to argue against an important contribution of a8 integrin to placental function or, alternatively, might indicate effective compensatory mechanisms, which might substitute for a lack in a8 integrin expression. Human studies revealed that recessive mutations in the a8 integrin gene can lead to bilateral renal agenesis resulting in abortions, 65 which is in line with the findings in a8 integrin-deficient mice. 23 Human placentas were not investigated for mutations in the a8 integrin gene thus far. One has to keep in mind, however, that the murine placenta is somewhat different in comparison with human placenta. 50, 66 Beyond their common hemochorial nature (trophoblast in contact with maternal blood), rodent placenta varies from human placenta due to its organization in junctional and labyrinthine zones (reviewed by Dilworth MR and Sibley 50 ). Although the former is associated with endocrine function, the latter comprises the maternofetal exchange layer. The trophoblast cells of the junctional zone (ST, glycogen, and GCs) share similarities with human EVT, [67] [68] [69] [70] whereas the rodent labyrinth resembles the human SCT as maternofetal exchange surface.
Interestingly, the architecture of the rodent labyrinth is hemotri-chorial, compared to the hemo-mono-chorial SCT of the human placenta, consisting of sinusoidal trophoblast GCs and 2 syncytial trophoblast layers. 50, 71, 72 Comparison of placentas among the studied species revealed that only mouse placenta shared syncytial a8 integrin expression with human placenta. Although in humans and rats the syncytium remained FN negative, the murine syncytium showed a positive FN immunoreactivity. This might suggest that in the human placenta, syncytial a8 integrin possibly interacts with binding partners other than FN, such as nephronectin, 73 tenascin, 74 or vitronectin. 75 In analogy to the human EVT, the GCs of both rat and mouse showed a positive a8 integrin, FN, and OPN staining, arguing for an interaction of these proteins in the junctional zone. An important function of FN is its ability to strengthen EVT basal plate adhesion and its support of trophoblast migratory function 76 in embryogenesis. 77 To study a possible role for a8 integrin in the development of the murine placenta, we analyzed placentas from homozygous a8 integrin-deficient mice. We detected a reduced CD31 immunoreactivity, indicative of alterations of labyrinth layer vascularity. Welser et al 16 showed that a7 integrin null embryos exhibit vascular smooth muscle cell defects that result in a reduced vascularity of the labyrinth layer and contribute to the partial embryonic lethality. Similarly, a8 integrin, which is abundantly expressed in smooth muscle of the vasculature, 78 regulates smooth muscle function 28, 60 and underexpression of a8 integrin results in an increased susceptibility to develop atherosclerotic lesions and arterial remodeling. 27 However, the observed change in placental vascularity seems to be only a subtle alteration, as the expression of the endothelial cell marker CD31 was not different in mice lacking the a8 integrin. Moreover, the placental deficiency for a8 integrin seems to be largely compensated for, as it was not reflected by a reduction in birth weight in these animals. There are some candidate integrins, which might compensate for the lack of a8 integrin. a5 integrin and av integrin are integrins that share many characteristics with a8 integrin and might thus maintain tissue integrity in placentas with a deficiency for a8 integrin. On the other hand, a8 integrindeficient renal mesangial cells upregulate the expression of a2 integrin and a6 integrin. 79, 80 Thus, these integrins might also be candidates for compensatory effects. 26 Expression analysis of these integrins, however, did not reveal differences in a8 integrin-deficient and WT placentas, arguing against a contribution of these integrins to any compensation for the lack of a8 integrin.
Taken together, we describe trophoblast a8 integrin expression in human and rodent placenta. We demonstrate species-specific expression patterns of a8 integrin and its binding partners FN and OPN in the syncytium, yet homogenous coexpression in the EVT and GC among the different species. As signaling via a8 integrin is known to be involved in several cell functions such as cell proliferation, apoptosis or adhesion, and migration, it is conceivable that a8 integrin Polymerase chain reaction (PCR) results of various integrins and CD31 obtained from total placentas of a8 integrin-deficient (Itga8 À/À , n ¼ 5) and WT (n ¼ 7) mice. Data are given as fold-change compared to WT (mean + standard error of the mean [SEM]). b P < .001. c Not significant. Figure 5 . Labyrinth vascularity and neonatal body weights in a8 integrin-deficient mice. A, The quantitative analysis of the labyrinth vascularity via CD31 staining (immunofluorescence with secondary antibody coupled to Cy3) in a8 integrin-deficient (Itga8 À/À ) and WT mice (representative of n ¼ 5, each). wP < .05. B, The birth weights (mean + SD) of a8 integrin-deficient (Itga8 À/À ) and WT mice in grams (n ¼ 22 WT, n ¼16 Itga8 À/À , from 5 different litters). IR indicates immunoreactivity; SD, standard deviation; WT, wild-type.
contributes to normal placental development and helps to maintain structural integrity of the placenta. Given the fact that a8 integrin deficiency does not lead to an adverse fetal outcome, we suspect that placental a8 integrin function can be compensated for. However, lack of placental a8 integrin might nevertheless predispose to placental failure following a second hit (eg, infection, malnutrition), as shown for other organs such as the kidney and vasculature 27, 81 in a8 integrin-deficient mice.
